103,951
Participants
Start Date
January 1, 2011
Primary Completion Date
September 30, 2015
Study Completion Date
January 31, 2019
Long- and intermediate- acting insulins
alone or in combination with metformin, short-acting insulin, or second-generation sulfonylurea
Collaborators (5)
HealthCore, Inc.
INDUSTRY
Aetna, Inc.
INDUSTRY
University of Alabama; Rheumatologist and Healthcare Research
UNKNOWN
AbbVie
INDUSTRY
Amgen
INDUSTRY
Boehringer Ingelheim
INDUSTRY
Kaiser Permanente
OTHER
Harvard Pilgrim Health Care
OTHER
Merck Sharp & Dohme LLC
INDUSTRY
Momenta Pharmaceuticals, Inc.
INDUSTRY
Pfizer
INDUSTRY
University of Pittsburgh
OTHER
Biologics & Biosimilars Collective Intelligence Consortium
OTHER